Medical Ripple Therapeutics Announces Collaboration and Option-to-License Agreement with AbbVie to Develop Next-Generation Therapies for Glaucoma ManagementBy Marie JonesSeptember 17, 2024 – Collaboration to leverage AbbVie’s eye care expertise and Ripple’s innovative drug delivery platform to develop next-generation sustained release drug…
